GSA Capital Partners LLP Buys Shares of 33,244 Centene Corporation $CNC

GSA Capital Partners LLP purchased a new stake in shares of Centene Corporation (NYSE:CNC) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 33,244 shares of the company’s stock, valued at approximately $2,134,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CNC. DV Equities LLC acquired a new position in Centene in the 4th quarter valued at approximately $26,000. IFC & Insurance Marketing Inc. acquired a new position in shares of Centene during the fourth quarter worth $28,000. SBI Securities Co. Ltd. grew its stake in shares of Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after purchasing an additional 406 shares during the last quarter. Bayban acquired a new stake in Centene in the fourth quarter valued at $33,000. Finally, MV Capital Management Inc. bought a new position in Centene during the 4th quarter worth $34,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Trading Up 2.3%

NYSE CNC opened at $67.53 on Friday. The stock has a market capitalization of $33.36 billion, a P/E ratio of -6.47, a P/E/G ratio of 0.36 and a beta of 1.08. The business has a 50 day simple moving average of $65.00 and a 200 day simple moving average of $51.65. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. Centene Corporation has a one year low of $27.76 and a one year high of $69.36.

Centene (NYSE:CNC) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $2.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $1.42. The firm had revenue of $53.58 billion for the quarter, compared to analyst estimates of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The company’s revenue was up 9.9% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.16) earnings per share. Centene has set its FY 2026 guidance at 4.800- EPS. Research analysts expect that Centene Corporation will post 4.89 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CNC has been the topic of a number of analyst reports. Wells Fargo & Company set a $69.00 price target on Centene and gave the company an “equal weight” rating in a research report on Monday, July 13th. Royal Bank Of Canada lifted their price objective on Centene from $70.00 to $71.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Stifel Nicolaus set a $79.00 target price on Centene in a report on Monday, August 3rd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research note on Friday, July 17th. Finally, Raymond James Financial set a $75.00 price objective on shares of Centene in a research report on Tuesday, July 7th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Centene has a consensus rating of “Hold” and an average price target of $69.15.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.